BioSpace News Archive

Drug Development

Aravive and AstraZeneca Announce Initiation of Randomized Phase 1/2 Study of AVB-500 in Combination with Durvalumab in Patients with Platinum-Resistant Recurrent Epithelial Ovarian Cancer

Investigator-sponsored study being conducted in clinical collaboration with Aravive and AstraZeneca

November 12, 2019
·
6 min read
Genetown

Boston Scientific Completes €900 million Offering of Senior Notes and $1.0 billion Tender Offer

The Company has applied to list the Notes on the New York Stock Exchange.

November 12, 2019
·
3 min read
Drug Development

Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting

New analysis from Phase 4 study in RA showed that statistically significant improvement from baseline in patient-reported outcomes for pain, fatigue, physical functioning and work-related impairment was associated with Acthar Gel treatment

November 12, 2019
·
16 min read
Business

Pri-Med and Sjögren’s Syndrome Foundation Partner to Develop Autoimmune Disease Education at the Pri-Med East Primary Care CME/CE Conference

Pri-Med East is a four-day CME/CE conference at the Boston Convention & Exhibition Center in Boston, MA, that will feature more than 60 sessions and workshops designed for primary care clinicians from throughout the northeastern U.S.

November 12, 2019
·
2 min read
Business

Catalyst Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Firdapse® Launch Momentum Continues with Q3 Net Revenues of $30.9 Million

November 12, 2019
·
11 min read
Pharm Country

Therap Offers Variety of Tools for Health Care Support Professionals

Meds are scheduled and comments may be added to medication passes and treatment records, while reports export to a monthly grid for immediate review, by a licensed nurse for example.

November 12, 2019
·
2 min read
BioCapital

Trio Health Reports on Outpatient Costs for Individuals with Rheumatoid Arthritis (RA) Treated in the U.S. Community Practices

Real-world study results in patients with rheumatoid arthritis presented at the Annual Meeting of the American College of Rheumatology

November 12, 2019
·
2 min read
Business

Cardiovascular Systems, Inc. Announces Stephen Stenbeck Joins Board of Directors

Brent Blackey Retires after 12 Years of Service

November 12, 2019
·
2 min read
Business

Melinta Therapeutics Files Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2019

The Company encourages its current and potential investors to read this quarterly report for information related to our third quarter 2019 financial results and other important corporate updates.

November 12, 2019
·
7 min read
Business

RubrYc Therapeutics Appoints Rakesh Verma, Ph.D. as SVP Discovery & Development

RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies to improve outcomes for cancer and serious autoimmune disease patients, announced the appointment of Rakesh Verma, Ph.D., as the Company’s Senior Vice President, Discovery & Development.

November 12, 2019
·
3 min read